Patient Outcomes

Participants who stopped antidepressants described renewed emotional range, restored autonomy, and stronger identity. The study evaluates whether faster dose optimisation improves symptoms, health-related quality of life, and work absence. Several participants were surprised and relieved that they could function normally without medication. Wearable technologies may support continuous monitoring, faster diagnosis, and greater patient involvement in health management. Earlier, more regular, and more accurate vital sign measurement could support better triage and early treatment. Lower post-training mortality in the intervention arms should not be interpreted as evidence of efficacy because the pilot was underpowered and cluster heterogeneity may confound the comparison. Twenty participants began reducing their antidepressant dose, and eight stopped entirely. The planned review will examine how studies characterize wearable technology effectiveness on patient outcomes. The interviewed sample covered diverse ages, antidepressant durations, medication types, and tapering stages. Strength changes are treated cautiously because certainty-only changes may not substantially change net ben…